Literature DB >> 21388582

Heart rate variability in facioscapulohumeral muscular dystrophy.

Giacomo Della Marca1, Roberto Frusciante, Michele Scatena, Serena Dittoni, Elisa Testani, Catello Vollono, Anna Losurdo, Emanuele Scarano, Salvatore Colicchio, Benedetto Farina, Valentina Gnoni, Salvatore Mazza, Pietro Attilio Tonali, Enzo Ricci.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is the third most frequent form of muscular dystrophy. Heart rate variability (HRV) analysis is a means of evaluating the activity of the autonomic nervous system. The aim of this study was to evaluate HRV in FSHD patients. Fifty-five consecutive FSHD patients were enrolled (31 men, age 26-72 years). Muscular impairment was measured using a clinical severity scale (CSS). Patients were compared with a control group of 55 healthy subjects, matched for age and sex. HRV was analyzed in the time domain and in the frequency domain. Patients showed increased spectral power of the low-frequency band. Spectral power of the high-frequency band was inversely correlated with CSS score. FSHD is associated with a slight increase in sympathetic output and with a decrease in parasympathetic output. These modifications become more evident with the progression of the disease and could increase the risk of arrhythmias and other cardiovascular events.

Entities:  

Mesh:

Year:  2010        PMID: 21388582

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  11 in total

1.  Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.

Authors:  Rasna Sabharwal; Michael Z Cicha; Ruben D M Sinisterra; Frederico B De Sousa; Robson A Santos; Mark W Chapleau
Journal:  Clin Sci (Lond)       Date:  2014-07       Impact factor: 6.124

2.  Angiotensin-dependent autonomic dysregulation precedes dilated cardiomyopathy in a mouse model of muscular dystrophy.

Authors:  Rasna Sabharwal; Robert M Weiss; Kathy Zimmerman; Oliver Domenig; Michael Z Cicha; Mark W Chapleau
Journal:  Exp Physiol       Date:  2015-06-15       Impact factor: 2.969

3.  Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  Allison Ducharme-Smith; Stefan Nicolau; C Anwar A Chahal; Kirstie Ducharme-Smith; Shujah Rehman; Keerthi Jaliparthy; Nadeem Khan; Christopher G Scott; Erik K St Louis; Teerin Liewluck; Virend K Somers; Grace Lin; Peter A Brady; Margherita Milone
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

4.  Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure.

Authors:  Thomas G Hampton; Ajit Kale; Scott McCue; Hemmi N Bhagavan; Case Vandongen
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

Review 5.  Autonomic dysfunction in muscular dystrophy: a theoretical framework for muscle reflex involvement.

Authors:  Scott A Smith; Ryan M Downey; Jon W Williamson; Masaki Mizuno
Journal:  Front Physiol       Date:  2014-02-18       Impact factor: 4.566

Review 6.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

Review 7.  Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?

Authors:  Spandan Kalra; Federica Montanaro; Chris Denning
Journal:  J Neuromuscul Dis       Date:  2016-08-30

8.  Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).

Authors:  Eugénie Ansseau; Céline Vanderplanck; Armelle Wauters; Scott Q Harper; Frédérique Coppée; Alexandra Belayew
Journal:  Genes (Basel)       Date:  2017-03-03       Impact factor: 4.096

9.  Autonomic regulation in muscular dystrophy.

Authors:  Corrado Angelini; Rita Di Leo; Paola Cudia
Journal:  Front Physiol       Date:  2013-09-20       Impact factor: 4.566

10.  The link between stress disorders and autonomic dysfunction in muscular dystrophy.

Authors:  Rasna Sabharwal
Journal:  Front Physiol       Date:  2014-01-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.